書籍詳細

第1編 試験管, 細胞レベルの実験モデルと評価法

P.28 掲載の参考文献

• 1) Matsui T., Matsumoto, K.: Antihypertensive peptides from natural resources. In: Lead Molecules from Natural Products: Discovery and Trends, Khan M.T.H., Ather A. (ed), Elsevier B.V., The Netherlands, 2006, p259-276.

• 2) Matsui T., Ogunwande I., Abesundara K.J.M. et al.: Anti-hyperglycemic potential of natural products. Mini-Reviews in Medicinal Chemistry 2006 ; 6 ; 109-120.

• 3) Koukoulitsa C., Zika C., Geromichalos G.D. et al.: Evaluation of aldose reductasen inhibition and docking studies of some secondary metabolites, isolated from Origaum vulgare L. ssp. hirtum. Bioorg Med Chem 2006; 14; 1653-1659.

• 4) 景山茂編: 糖尿病治療薬の選び方と使い方. 南江堂, 1996.

• 5) Teshima S., Mitsuhida N., Ando M.: Determination of α-amylase in biological fluids using a new substrate (β-2-chloro-4-nitrophenyl-maltopentanoside). Clin Chim Acta 1985; 150; 165-174.

• 6) 松井利郎: 食品成分による糖尿病予防. New Food Industry 2003; 45; 1-8.

• 7) Chiasson J.L., Josse R.G., Gomis R. et al.: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 2002; 359; 2072-2077.
  pubmed

• 8) 豊田隆謙: α-グルコシダーゼ阻害薬. ホルモンと臨床 1995; 43; 175-179.

• 9) 松井利郎, 松本清: 食品成分の生体調節機能-複合機能体の分析化学的評価-. 分析化学 2000; 49; 477-491.

• 10) Gamberucci A., Konta L., Colucci A. et al.: Green tea flavonols inhibit glucosidase II. Biochem Pharm 2006; 72; 640-646.
  pubmed

• 11) Kameda Y., Asano N., Yoshikawa M. et al.: Valiolamine, a new α-glucosidase inhibiting aminocyclitol produced by Streptomyces Hygroscopicus. J Antibiotics 1984; 17; 1301-1307.

• 12) Oki T., Matsui T., Osajima Y.: Inhibitory effect of α-glucosidase inhibitors varies according to its origin. J Agric Food Chem 1999; 47; 550-553.

• 13) Takeuchi M., Takai N., Asano N. et al.: Inhibitory effect of Validamine, Valienamine and Valiolamine on activities of carbohydrases in rat small intestinal brush border membranes. Chem Pharm Bull 1990; 38; 1970-1972.
  pubmed

• 14) Chandrasena G., Osterholm D.E., Sunitha I. et al.: Cloning and sequencing of full-length rat sucrase-isomaltase-encoding cDNA. Gene 1994; 150; 355-360.
  pubmed

• 15) 小高裕之, 三木七美, 池田衝ほか: 二糖類水解酵素阻害剤AO-128のラットにおける食後高血糖抑制作用. 日本栄養・食糧学会誌 1992; 45; 27-31.

• 16) Yoshikuni Y.: Inhibition of intestinal α-glucosidase activity and postprandial hyperglycemia by moranoline and its N-alkyl derivatives. Agric Biol Chem 1988; 52; 121-128.

• 17) Adisakwattana S., Sookkongwaree K., Roengsumran S. et al.: Structure-activity relationships of trans-cinnamic acid derivatives on α-glucosidase inhibition. Bioorg Med Chem Lett 2004; 14; 2893-2896.

• 18) Iwai K., Kim M.Y., Onodera A. et al.: α-Glucosidase inhibitory and antihyperglycemic effects of polyphenols in the fruit of Viburnum dilatatum Thunb. J Agric Food Chem 2006; 54; 4588-4592.

• 19) Watanabe J., Kawabata J., Kurihara H.: Isolation and identification of α-glucosidase inhibitors from Tochu-cha. Biosci Biotechnol Biochem 1997; 61;177-178.

• 20) 西川泰, 樫内賀子, 高田曜子ほか: インスリーナ葉抽出物のα-グルコシダーゼ阻害能の比較. 日本栄養・食糧学会誌 2003; 56; 375-378.
  Medical*Online

• 21) 吉川雅之, Pongpiriyadacha, 來住明宣ほか: タイ産Salacia chinensisの生物活性. 薬学雑誌 2003; 123; 871-880.

• 22) Yoshikawa M., Shimada H., Nishida N. et al.: Antidiabetic principles of natural medicines. Chem Pharm Bull 1998; 46; 113-119.
  pubmed

• 23) 鈴木裕子, 林和彦, 坂根巌ほか: バナバ葉抽出物のラットにおける食後血糖上昇抑制作用及びその作用様式. 日本栄養・食糧学会誌 2001; 54; 131-137.

• 24) Nishioka T., Watanabe J., Kawabata J. et al.: Isolation and activity of N-p-coumaroyltyramine, an α-glucosidase inhibitor in welsh onion. Biosci Biotechnol Biochem 1997; 61; 1138-1141.

• 25) Kurihara H., Ando J., Hatano M.: Sulfoquinovosyldiacylglycerol as an α-glucosidase inhibitor. Bioorg Med Chem Lett 1995; 5; 1241-1244.

• 26) Matsui T., Yoshimoto C., Osajima K. et al.: In vitro survey of α-glucosidase inhibitory food components. Biosci Biotechnol Biochem 1996; 60; 2019-2022.

• 27) Matsui T., Oki T., Osajima Y.: Isolation and identification of peptidic α-gluosidase inhibitors derived from sardine mucle hydrolyzate. Z Naturforsch 1999; 54C; 259-263.

• 28) Shim Y.J., Doo H.K., Ahn S.Y. et al.: Inhibitory effect of aqueous extract from the gall of Rhus chinensis on alpha-glucosidase activity and postprandial blood glucose. J Enthnopharm 2003; 85; 283-287.
  pubmed

• 29) 浅野敏彦, 吉村康美, 橡田清彦: ラットにおけるD-キシロースのスクラーゼ阻害作用と血糖上昇抑制作用. 日本栄養・食糧学会誌 1996; 49; 157-162.

• 30) Ali M.S., Jahangir M., Hussan S.S. et al.: Inhibition of α-glucosidase by oleanolic acid and its synthetic derivatives. Phytochemistry 2002; 60; 295-299.

• 31) Kim J.S., Kwon C.S., Son K.H.: Inhibition of alpha-glucosidase and amylasey by luteolin, a flavonoid. Biosci Biotechnol Biochem 2000; 64; 2458-2461.
  pubmed

• 32) Seri K., Sanai K., Matsuo N. et al.: L-Arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals. Metabolism 1996; 45; 1368-1374.

• 33) Honda M., Hara Y. inhibition of rat small intestinal sucrase and α-glucosidase activities by tea polyphenols. Biosci Biotechnol Biochem 1993; 57; 123-124.

• 34) Du Z.Y., Liu R.R., Shao W.Y. et al.:α-Glucosidase inhibition of natural curcuminoids and curcumin analogs. Eur J Med Chem 2006; 41; 213-218.

• 35) Lee H.S.: Cuminaldehyde: aldose reductase and α-glucosidase inhibitor derivedrom Cuminum cyminum L. seeds. J Agric Food Chem 2005; 53; 2446-2450.

• 36) Oki T., Matsui T., Matsumoto K.: Evaluation of α-glucosidase inhibition by using an immobilized assay system. Biol Pharm Bull 2000; 23; 1084-1087.

• 37) 武藤泰敏編著: 消化・吸収. 第一出版, 2002, p.124-127.

• 38) Matsui T., Kobayashi M., Hayashida S. et al.: Luteolin, a flavone, does not suppress postprandial glucose absorption through an inhibition of α-glucosidasection. Biosci Biotechnol Biochem 2002; 66; 689-692.

• 39) Matsui T., Ebuchi S., Fukui K. et al.: Caffeoylsophorose, A new natural α-lucosidase inhibitor, from red vinegar by fermented purple-fleshed sweet potato. Biosci Biotechnol Biochem 2004; 68; 332-339.

• 40) Matsui T., Ebuchi S., Fujise T. et al.: Strong antihyperglycemic effects of water-soluble fraction of Brazilian propolis and its bioactive constituent, 3, 4, 5-tri-O-caffeoylquinic acid. Biol Pharm Bull 2004; 27; 1797-1803

• 41) Matsui T., Ueda T., Oki T. et al.: α-Glucosidase inhibitory action of natural acylated anthocyanins. 2. α-Glucosidase inhibition by isolated acylated anthocyanins. J Agric Food Chem 2001; 49; 1952-1956.

• 42) Abesundara K.J.M., Matsui T., Matsumoto K.: α-Glucosidase inhibitory activity of some Sri Lanka plant extracts, One of which, Cassia auriculata, exerts strong antihyperglycemic effect in rats comparable to the therapeutic drug acarbose. J Agric Food Chem 2004; 52; 2541-2544.

• 43) Matsui T., Ebuchi S., Kobayashi M. et al.: Anti-hyperglycemic effect of diacylated anthocyanin derived from Ipomoea batatas cv. Ayamurasaki can be achieved through the α-glucosidase inhibitory action. J Agric Food Chem 2002; 50; 7244-7248.

• 44) Matsui T., Tanaka T., Tamura S. et al.: α-Glucosidase inhibitory profile of catechins and theaflavins. J. Agric Food Chem 2007; 55; 99-105.

第2章 脂肪細胞の特性を生かした食品因子の生理機能評価

P.46 掲載の参考文献

• 1) Matsuzawa Y.: Adipocytokines and metabolic syndrome. Semin Vasc Med 2005; 5: 34-39.
  pubmed

• 2) Friedman J.M., Halaas J.L.: Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770.
  pubmed

• 3) Maeda K., Okubo K., Shimomura I. et al.: cDNA cloning and expression of novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant gene transcript 1). Biochem Biophys Res Commun 1996; 221: 16286-16289.

• 4) Arita Y., Kihara S., Ouchi N. et al.: Paradoxical decrease of an adipose-specificrotein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
  pubmed

• 5) Bajaj M., Suraamornkul S., Piper P. et al.: Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insuline resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinoletab 2004; 89:200-206.

• 6) Diez J.J., Iglesias P.: The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148: 293-300.
  pubmed

• 7) Shimomura I., Funahashi, T., Takahashi M. et al.: Enhanced expression of AI-1 in visceral fat: possible contributor to vascular disease in obesity. Nated 1996; 2: 800-803.

• 8) Sartipy P., Loskutoff D. J.: Monocyte chemoattractant protein 1 in obesitynd insulin resistance. Proc Natl Acad Sci USA 2003; 100: 7265-7270.
  pubmed

• 9) Weisberg S.P., McCann D., Desai M. et al.: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
  pubmed

• 10) Xu H., Barnes G.T., Yang Q. et al.: Chronic inflammation in fat plays a crucial role in the development of obesity related insulin resistance. J Clin Invest 2003; 112: 1821-1830.

• 11) Suganami T., Nishida J., Ogawa Y.: A paracrine loop between adipocytes andacrophages aggravates inflammatory changes: role of free fatty acids andumor necrosis factor alpha. Arterioscler Thromb Vasc Biol. 2005; 25: 20622068.

• 12) Kanda H., Tateya S., Tamori Y. et al.: MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. Clin Invest 2006; 116: 1494-1505.
  pubmed

• 13) Ozcan U., Cao Q., Yilmaz E.: Endoplasmic reticulum stress links obesity, insulinction, and type 2 diabetes. Science. 2004; 306: 457-461.
  pubmed

• 14) Furukawa S., Fujita T., Shimabukuro M. et al.: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
  pubmed

• 15) Green H., Meuth M.: An established pre-adipose cell line and its differentiation culture. Cell. 1974; 3: 127-133.
  pubmed

• 16) Rodbell M.: Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 1964; 239: 375-380.
  pubmed

• 17) Sugihara H., Yonemitsu N., Miyabara S. et al.: Primary cultures of unilocular fat cells: characteristics of growth in vitro and changes in differentiation properties. Differentiation. 1986; 31: 42-49.
  pubmed

• 18) Sugihara H., Yonemitsu N., Toda S. et al.: Unilocular fat cells in three-dimensional collagen gel matrix culture. J Lipid Res. 1988; 29: 691-697.
  pubmed

• 19) Tsuda T., Ueno Y., Aoki H. et al.: Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. Biochemiophys Res Commn 2004; 316: 149-157.

• 20) Woods A., Johnstone S.R., Dickerson K., et al.: LKB1 is the upstream kinasen the AMP-activated protein kinase cascade. Curr Biol 2003; 13: 2004-2008.

• 21) Hardie D.G., Scott J.W., Pan D.A.: Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 2003; 546: 113-120.
  pubmed

• 22) Minokoshi Y., Kim Y.-B., Peroni O.D.: Leptin stimulates fatty-acid oxidationy activating AMP-activated protein kinase Nature 2002; 415: 339-343.
  pubmed

• 23) Yamauchi T., Kamon J., Minokoshi Y. et al.: Adiponectin stimulates glucosetilization and fatty-acid oxidation by activating AMP - activated protein kinase. Nat Med 2002; 8 :1288-1295.
  pubmed

• 24) Wu X., Motoshima H., Mahadev K. et al.: Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin primary rat adipocytes. Diabetes 2003; 52: 1355-1363.
  pubmed

• 25) Tsuda, T., Ueno Y., Kojo, H. et al.: Gene expression profile of isolated rat adipocytes treated with anthocyanins. Biochim Biophys Acta 2005; 1733: 137-147.
  pubmed

• 26) Tsuda T., Ueno Y., Yoshikawa T. et al.: Microarray profiling of gene expression in human adipocytes in response to anthocyanins. Biochem Pharmacol 2006; 71: 1184-1197.
  pubmed

• 27) Eriksson P., Reynisdottir S., Lonnqvist F.: Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia 1998; 41: 65-71.
  pubmed

• 28) Juhan-Vague I., Alessi M.C., Mavri A. et al.: Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost 2003; 1: 1575-1579.

• 29) Pradhan A.D., Manson J.E., Rifai N. et al.: C-reactive protein, interleukin 6,nd risk of developing type 2 diabetes mellitus. J Am Med Assoc 2001; 286:327-334.

• 30) Rega G., Kaun G.C., Weiss T.W. et al.: Inflammatory cytokines interleukin-6nd oncostatin M induce plasminogen Activator Inhibitor-1 in human adipose tissue. Circulation 2005; 111: 1938-1945.

第3章 TRPV1を活性化する食品成分

P.66 掲載の参考文献

• 1) Zhang Y., Proenca R., Maffei M. et al.: Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372; 425-432.
  pubmed

• 2) 森山達哉, 河田照雄: 脂肪組織とアディポサイトカイン. 脂質栄養と健康(宮澤陽夫, 柳田晃良, 藤本健四郎編), 建帛社, 2005, p194-216.

• 3) Westerterp K.R.: Diet induced thermogenesis. Nutr Metab 2004; 1(5); 1-5.
  pubmed

• 4) 辛味成分の生理作用. トウガラシ-辛味の科学(岩井和夫, 渡辺達夫編), 幸書房, 2000, p148-228.

• 5) Caterina M.J., Schumacher M.A., Tominaga M. et al.: The capsaicin receptor: heat-activated ion channel in the pain pathway. Nature 1997; 389; 816-824.
  pubmed

• 6) Tominaga T., Tominaga M.: Structure and function of TRPV1. Pflugersrch (Eur J Physiol ) 2005; 451; 143-150.

• 7) Iwai K., Yazawa A., Watanabe T.:Roles as metabolic regulators of the non-nutrients, capsaicin and capsiate, supplemented to diets. Proc Japan Acad 2003; 79B; 207-212.

• 8) Kawada T., Suzuki T., Takahashi M., Iwai K.-Gastrointestinal absorption and metabolism of capsaicin and dihydrocapsaicin in rats. Toxicol Appl Pharmacol 1984; 72; 449-456.
  pubmed

• 9) Watanabe T., Kawada T., Kurosawa M. et al.: Adrenal sympathetic efferent nerve and catecholamine secretion excitation caused by capsaicin in rats. Am Physiol 1988; 255; E23-27.
  pubmed

• 10) Kawada T., Hagihara K., Iwai K.: Effects of capsaicin on lipid metabolism in fats fed a high fat diet. J Nutr 1986; 116; 1272-1278.
  pubmed

• 11) Kawada T., Sakabe S., Aoki N. et al.: Intake of sweeteners and pungent ingredients increases the thermogenin content in brown adipose tissue of rat. Jgric Food Chem 1991; 39; 651-654.

• 12) Ohnuki K., Haramizu S., Watanabe T. et al.: CH-19 Sweet, nonpungent cultivarf red pepper, increased body temperature in mice with vanilloid receptor stimulation by capsiate. J Nutr Sci Vitaminol 2001; 47; 295-298.

• 13) Watanabe T., Kawada T., Iwai K.: Effect of capsaicin pretreatment on capsaicin-induced catecholamine secretion from the adrenal medulla in rats. Prococ Exp Biol Med 1988; 187; 370-374.

• 14) Watanabe T., Sakurada N., Kobata K.Capsaicin-, resiniferatoxin-, and olvanil-induced adrenaline secretions in rats via the vanilloid receptor. Biotechnol Biochem 2001; 65; 2443-2447.
  pubmed

• 15) Morita A., Iwasaki Y., Kobata K., et al.: Lipophilicity of capsaicinoids and apsinoids influences the multiple activation process of rat TRPV1. Life Sci 2006; 79; 2303-2310.
  pubmed

• 16) Grynkiewicz G., Poenie M., Tsien R.Y.: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260; 3440-3450.
  pubmed

• 17) 岡田泰伸編: 新パッチクランプ実験技術法. 吉岡書店, 2001.

• 18) Kobata K., Iwasawa T., Iwasaki Y. et al.: Capsaicinol: synthesis by allylic oxidation and its effect on TRPV1-expressing cells and adrenaline secretionn rats. Biosci Biotechol Biochem 2006; 70; 1904-1912.

• 19) Szolcsanyi J., Jancso-Gabor A.: Sensory effects of capsaicin congeners. Arzneim-Forsch (Drug Res) 1975; 25; 1877-1881.

• 20) Iida T., Moriyama T., Kobata K. et al.: TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate.europharmacology. 2003; 44; 958-967. Jun; 44(7): 958-67.

• 21) Calixto J.B., Kassuya C.A., Andre E. et al.-Contribution of natural products to the discovery of the transient receptor potential(TRP) channels family andheir functions. Pharmacol Ther 2005; 106; 179-208.

• 22) 矢澤進, 末留昇, 岡本佳奈ほか: 'CH-19甘'を片親としたトウガラシ(Capsicum annuum L.) の雑種におけるカプサイシノイドならびにカプサイシノイド様物質の含量. 園芸学会雑誌 1989; 58; 601-607.

• 23) Kobata K., Todo T., Yazawa S. et al. Novel capsaicin-like substances, capsiate and dihydrocapsiate, from the fruits of a nonpungent cultivar, CH-19weet, of pepper(Capsicum annuum L.). J Agric Food Chem 1998; 46; 1695-1697.

• 24) Masuda T., Kikuzaki H., Tachibana Y. et al.: Synthesis of capsaicinol [1]. Chem Express 1990; 5; 369-372.

• 25) Sugai E., Morimitsu Y., Iwasaki Y. et al.: Pungent qualities of sanshool-related compounds evaluated by a sensory test and activation of rat TRPV1. Biosci Biotechnol Biochem 2005; 69; 1951-1957.
  pubmed

• 26) Iwasaki Y., Morita A, Iwasawa T. et al.: A nonpungent component of steamed ginger- [10]-shogaol-increased adrenaline secretion via the activation of TRPV1. Nutr Neurosci 2006; 9; 169-178.
  pubmed

• 27) Govindarajan V.S.: Ginger - chemistry, technology, and quality evaluation: part 2. CRC Crit Rev Food Sci Nutr 1982; 17; 189-258(p.234, Table 50).

第2編 組織, 動物個体レベルの実験モデルと評価法

P.97 掲載の参考文献

• 1) 池田恒彦: 神経細胞とグリア細胞の干渉(代謝). やさしい眼の細胞・分子生物学, 文光堂, 1996, p248-251.

• 2) 岡本直之: 変性網膜の代謝. やさしい眼の細胞・分子生物学, 文光堂, 1996, p278-282.

• 3) 吉沢透: 視物質. 新生理科学大系 第9巻 感覚の生理学(田崎京二, 小川哲朗編), 医学書院, 1989, p76-89.

• 4) 深田吉孝: 視細胞における光受容体とGタンパク質の機能と構造. 生化学 1993; 65; 513-536.

• 5) Dratz E.A. and Hargrave P.A.:The structure of rhodopsin and the rod outer segment disk membrane. Trends in Biol. Sci 1983; 4; 128-131.

• 6) Hubbel W., Bownds M. D.:Visual transduction invertrebrate photoreception. Ann. Rev. Neurosci 1979; 2; 17-34.

• 7) 阿部俊明: 視物質の代謝・遺伝. やさしい眼の細胞・分子生物学, 文光堂, 1996, p252-255.

• 8) Stuart P., Richer O. D.:Is there a prevention and treatment strategy for macular degeneration. J. Am. Optom. Assoc 1993; 64; 838-850.

• 9) 安東えい子, 安東由喜雄, 井上正康: 眼科疾患と活性酸素. 活性酸素と病態-疾患モデルからベッドサイドへ-(井上正康編), 学会出版センター, 1992, p557-565.

• 10) 山川良治: アラキドン酸カスケード. やさしい眼の細胞・分子生物学, 文光堂, 1996, p64-69.

• 11) Morales H.P.:Retinal degeneration induced by taurine deficiency in light-derived cats. Exp. Eye Res 1986; 43; 55-60.

• 12) Matsumoto H., Hanamura S., Kawakami T. et al.:Preparative-scale isolation of four anthocyanin components of black currant (Ribes nigrum L.) fruits. J. gric. Food Chem 2001; 49; 1541-1545.

• 13) Tsuda T., Horio F., Osawa T.:Absorption and metabolism of cyanidin 3-O-β-D-glucoside in rats. FEBS Lett 1999; 449(2-3); 179-182.

• 14) Felgines C., Talavera S., Gonthier M. P.:Strawberry anthocyanins are recovered in urine as glucuro-and sulfoconjugates in humans. J. Nutr 2003; 133(5); 1296-1301.
  pubmed

• 15) Matsumoto H., Inaba H., Kishi M. et al.:Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J. Agric. Food Chem. 2001; 49; 1546-1551.
  pubmed

• 16) Matsumoto H., Nakamura Y., Iida H. et al.:Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues. Exp Eyees 2006; 83(2); 348-56.
  pubmed

• 17) Nakaishi H., Matsumoto H., Tominaga S. et al.:Effects of blackcurrant anthocyanosides intake on dark adaptation and VDT work-induced transient refractive alternation in healthy humans. Altern. Med. Rev. 2000; 5(6); 553562.

• 18) 松本均, 中村裕子, 徳永隆久ほか: VDT作業時の調節機能低下へのカシスアントシアニン摂取の影響. あたらしい眼科 2006; 23(1); 129-133.
  Medical*Online

• 19) Matsumoto H., Kamm K. E., Stull J. T. et al.:Delphinidin-3-rutinoside relaxes the bovine ciliary smooth musde through activation of ETB receptor and NO/cGMP pathway. Exp. Eye. Res 2005; 80, 313-322.

• 20) Bastide P., Rouher F., Tronche P.:[Rhodopsin and anthocyanosides. Apropos of various experimental facts.] Bulletin des Societes D'Ophtalmologie de France. 1968; 9; 801-807.
  pubmed

• 21) Matsumoto H., Nakamura Y., Tachibanaki S. et al.:Stimulatory effect of cyanidinlycosides on regeneration of rhodopsin. J. Agric. Food. Chem. 2003;51(12); 3560-3563.
  pubmed

• 22) Knowles A., Prisestley A.:The preparation of 11-cis-retinal. Vision Res.1978; 18; 115-116.
  pubmed

• 23) Kawamura S., Bownds M. D.:Light adaption of the cyclic GMP phosphodiesterase of frog photoreceptor membranes mediated by ATP and calcium ions. J. Gen. Physiol. 1981; 77; 571-591.
  pubmed

• 24) Hanselman A. R., Cusanovish, M. A.:Characterization of the recombination reaction of rhodopsin. Biochemistry. 1976; 15; 5321-5325.

• 25) Virmaux N., Bizec J. C., Nullans G. et al.:Modulation of rod cyclic GMP-phosphodiesterase activity by anthocyanin derivatives. Biochemical Society Transactions. 1990; 18; 686-687.
  pubmed

• 26) Kawamura, S.:Rhodopsin phosphorylation as a mechanism of cyclic GMP phosphodiesterase regulation by S-modulin. Nature. 1993; 362; 855-857.

第5章 食品成分と脳機能の行動評価法

P.113 掲載の参考文献

• 1) Sakato, Y.:Studies in the chemical constitution of tea. Part 1. On new amide theanine. Nippon Nougeikagaku Kaishi 1950;23;262-267.

• 2) 小西茂毅, 葛西善三郎: 茶樹における14CO2からのテアニン生成とその部位: 茶樹におけるテアニンおよびその関連物質の代謝と制御(第2報);日本土壌肥料學雜誌 1968; 39; 439-443.

• 3) Kimura R., Murata T.:Influence of alkylamides of glutamic acid and related compounds on the central nervous system. I. Central depressant effect of theanine. Chem Pharm Bull (Tokyo) 1971;19;1257-1261.

• 4) Kimura, R., Murata, T.:Effect of theanine on norepinephrine and serotonin levels in rat brain. Chem Pharmaceu. Bull (Tokyo) 1985;34;3053-3057.

• 5) Kakuda T., Nozawa A., Unno T. et al.:Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat. Biosci Biotechnol Biochem.2000;64;287-293.
  pubmed

• 6) Kitaoka S., Hayashi H., Yokogoshi H. et al.:Transmural potential changes associated with the in vitro absorption of theanine in the guinea pig intestine. Biosci Biotechnol Biochem. 1996;60;1768-1771.
  pubmed

• 7) Terashima T., Takido J., Yokogoshi H.:Time-dependent changes of amino acids in the serum, liver, brain and urine of rats administered with theanine. Biosci Biotechnol Biochem 1999;63;615-618.
  pubmed

• 8) Yokogoshi H., Mochizuki M., Saitoh K.-Theanine-induced reduction of brain serotonin concentration in rats. Biosci Biotechnol Biochem 1998;62;816-817.
  pubmed

• 9) Kimura R., Murata T.:Effect of theanine on norepinephrine and serotonin levels in rat brain. Chem Pharm Bull (Tokyo) 1986;34;3053-3057.
  pubmed

• 10) Yokogoshi H., Kobayashi M., Mochizuki M. et al.:Effect of theanine, γ-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res 1998;23;667-673.

• 11) 横越英彦, 寺島健彦: 緑茶成分(テアニン)の行動科学的解析. 必須アミノ酸研究, Reports of the Research Committee of Essential Amino Acids(Japan) 2000; 158; 27-37.

• 12) Juneja LR., Chu DC., Okubo T. et al.:L-theanine-a unique amino acid of green tea and its relaxation effect in humans. Trends in Food Science & Technology 1999;10;199-204.

第3編 食品の生理機能評価に有用な疾患モデル動物の開発

P.127 掲載の参考文献

• 1) International Human Genome Sequencing Consorthium:Initial sequencing and analysis of the human genome. Nature 2001;409;860-921.
  pubmed

• 2) Mouse Genome Sequencing Consortium:Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420;520-562.
  pubmed

• 3) Rat Genome Sequencing Project Consortium:Genome sequence of the brown Norway rat yields insights into mammalian evolution. Nature 2004;428;493-521.
  pubmed

• 4) Makino S., Kunimoto K. et al.:Breeding of non-obese diabetic strain of mice. Exp Anim 1980;29;1-13.

• 5) Komeda K., Noda M., Terao K. et al.:Establishment of two substrains, diabetes-rone and non-diabetic, from Long-Evans Tokushima Lean(LETL) rats.ndocr J 1998;45;737-744.

• 6) Chappel C.I. and Chappel W.R.:The discovery and development of BB rat colony:an animal model of spontaneous diabetes mellitus. Metabolism 1982;32;8-10.

• 7) Goto Y., Kakizaki M., Masaki N.:Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proc Jpn Acad 1975;51;80-85.

• 8) Kawano K., Hirashima T., Mori S. et al.:Spontaneous long-term hyperglycemic rat with diabetic complications; Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992;41;1422-1428.
  pubmed

• 9) Nishimura M.:Breeding of mice strain for diabetes mellitus. Exp Anim 1969;18;147-157.

• 10) Ikeda H., Shino A. et al.:A new genetically obese-hyperglycemic rat (Wistaratty). Diabetes 1981;30;1045-1050.
  pubmed

• 11) Peterson R.G. et al.:The Zucker diabetic fatty(ZDF) rat. In:Lessons from Animal Diabetes V, Shafrir E.(ed), Smith-Gordon, London, 1994, p225-230.

• 12) Nishimura M., Hirayama T., Serikawa K. et al.:The SMXA:a new set of recombinant inbred strain of mice consisting of 26 substrains and their genetic profile. Mamm Genome 1995;6;850-857.

• 13) Pataer A., Nishimura M., Kamoto T. et al.:Genetic resistance to urethan-induced pumonary adenomas in SMXA recombinant inbred mause starains. Cancer Res 1997;57;2904-2908.

• 14) Anunciado,R.V.P., Ohno T., Mori M. et al.:Distribution of body weight, blood insulin and lipid levels in the SMXA recombinant inbred strains and QTL analysis. Exp Anim 2000;49;217-224.

• 15) Kobayashi M., Io F., Horio F. et al.:SMXA-5 mouse as a diabetic model susceptible to feeding a high-fat diet. Biosci Biochem Biotech 2004;68;226230.

• 16) Kobayashi M., Ohno T., Horio F. et al.:Combinations of nondiabetic parental geniomes elicit impaired glucose tolerance in mouse S MXA-recombinant inbred strains. Diabetes 2003;52;180-186.

第7章 遺伝子機能に基づく疾患モデルマウスの開発 ―ENUミュータジェネシスによる生活習慣病モデルマウスの開発―

P.140 掲載の参考文献

• 1) Russell WL et al.:Proc Natl Acad Sci USA 1979;76;5818-5819.
  pubmed

• 2) Hitotsumachi S et al.:Proc Natl Acad Sci USA 1985;82;6619-6621.
  pubmed

• 3) Sakuraba Y et al.:Biochem Biophys Res Commun 2005;336;609-616.
  pubmed

• 4) Vitaterna MH et al.:Science 1994;264;719-725.
  pubmed

• 5) King DP et al.:Cell 1997;89;641-653.
  pubmed

• 6) 理化学研究所ゲノム科学総合研究センターゲノム機能情報研究グループ編: 細胞工学別冊実験プロトコールシリーズ マウス表現型解析プロトコール, 秀潤社, 2006.

• 7) Inoue M et al.:Hum Mol Genet 2004;13;1147-1157.
  pubmed

第4編 食品の生理機能評価を可能にする新たな評価用ツールの開発

P.165 掲載の参考文献

• 1) Fodor SP, Read JL, Pirrung MC, Stryer L, Lu AT and Solas D.:Light-directed, spatially 1 addressable parallel chemical synthesis. Science 1991;251;767-773.

• 2) Mark Schena, Dari Shalon, Ronald W. Davis, and Patrick O. Brown:Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray. Science 1995;270;467-470.

• 3) DeRisi, J.L., Iyer, V.R., and P.O. Brown:Exploring the Metabolic and Geneticontrol of Gene Expression on a Genomic Scale. Science 1997;278;680-686

• 4) Sakai-Kato, K., Kato, M., Ishihara, K. and Toyooka, T.:An enzyme-immobilization method for integration of biofunctions on a microchip using a water-soluble amphiphilic phospholipid polymer having a reacting group. Lab Chip 2004;4;4-6.
  pubmed

• 5) Kinoshita, Kenji et al.:Multiple primer extension by DNA polymerase on a novel plastic DNA array coated with a biocompatible polymer, Nucleic Acid Research(in press);2006.

• 6) Michikawa, Yuichi et al.:Reliable and fast kinetics allele-specific extension of 3'-LNA modified oligonucleotides covalently immobilized on a plastic base, combined with biotin-dUTP mediated optical detection. Analytical Sciences 2006;22;1537-1545.

第9章 分子認識光固定化法を用いた抗体チップの開発

P.177 掲載の参考文献

• 1) Y. Kawata, M. Tsuchimori, O. Watanabe et al.:Non-optically probing near-fieldmicroscopy. Opt. Commun 1999;161;6-12.

• 2) T. Ikawa, T. O. Watanabe, Y. Kawata et al.:Azobenzene polymer surface defomation due to the gradient force of the optical near field of monodispersed polystyrene spheres. Phys. Rev. B 2001;64;195408.

• 3) T. Ikawa, F. Hoshino, O. Watanabe et al.:Molecular-Shape Imprinting and Immobilization of Biomolecules on a Polymer Containing Azo Dye. Langmuir 2006;22;2747-2753.

• 4) O. Watanabe, T. Ikawa, H. Shimoyama et al.:Area-selective photoimmobilization of a two-dimensional array of colloidal spheres on a photodeformed template formed in photoresponsive azopolymer film. Appl. Phys. Lett. 88,(2006) 204107.

終章 食品の生理機能評価の新展開と将来展望

P.191 掲載の参考文献

• 1) 大澤俊彦: 生活習慣病とがん罹患リスク-肥満, 脂質摂取など. 医学と薬学 2006; 55(3); 311-321.
  Medical*Online

• 2) Diet, nutrition and the prevention of chronic diseases, WHO technical reporteries 916, 2003.
  pubmed

• 3) 大澤俊彦監修: がん予防食品開発の新展開-予防医学におけるバイオマーカーの評価システム-. シーエムシー出版, 2005.

• 4) 大澤俊彦: 「サプリメント」による抗老化療法の現状と展望. 日本老年医学会雑誌 2005; 42; 587-595.

• 5) 大澤俊彦: 世界の機能性食品開発の動向とCODEXの指針. 医薬ジャーナル 2005; 41(8); 2036-2043.

• 6) 大澤俊彦: 内外における新規機能性食品素材開発の近況. ジャパンフードサイエンス 2004; 43(12); 21-32.

• 7) 吉川敏一, 大澤俊彦監修: アンチエイジングと機能性食品-今なぜバイオマーカーか-. シーエムシー出版, 2006.

• 8) 阿部啓子, 荒井綜一: ニュートリゲノミクスと機能性食品. アンチエイジングと機能性食品-今なぜバイオマーカーか-(吉川敏一, 大沢俊彦監修), シーエムシー出版, 2006, p.207-213.

• 9) 大澤俊彦: 酸化傷害バイオマーカーの免疫化学的測定法. 酸化ストレスナビゲーター(倉林正彦監修, 山岸昌一編集), メディカルレビュー社, 2005, p.198-199.

• 10) Osawa, T.and Kato, Y.:Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia, Ann. N.Y. Acad. Sci. 2005;1043;440-451.
  pubmed

• 11) 大澤俊彦: フリーラジカルとアンチエイジング. 日本抗加齢医学会雑誌 2005; 1; 29-40.

• 12) 大澤俊彦: 酸化ストレス制御因子含有植物素材の探索と評価システム. 日本食品科学工学会誌 2005; 52(1); 7-8.